M. Murakoshi et al., Immunoreactive Pit-1 protein in hyperplastic pars intermedia induced by calcitonin of the rat pituitary gland, ENDOCR J, 47(1), 2000, pp. 13-20
To elucidate the effects of synthetic salmon calcitonin (sCT) on the cells
in the rat pituitary gland, we histopathologically and immunohistochemicall
y examined the early changes after 4 or 13 weeks treatment with sCT 120 IU/
kg. Focal proliferative lesions of the anterior pituitary glands were consi
stently found after treatment with sCT for 13 weeks. Histologically, the ce
lls with the focal proliferative lesions were classified into the following
three groups: 1) enlarged basophilic cell focus, 2) vacuolated cell focus
and 3) chromophobe cell focus. These focal proliferative lesions had positi
ve staining only for the alpha-subunit and failed to show Pit-1 protein imm
unoreactivity. The sCT treatment also increased the thickness of the pars i
ntermedia. Hypertrophy of the pars intermediate cells was characteristicall
y seen. Furthermore, Pit-1 protein immunoreactivity was clearly detected in
the nuclei of the hyperplastic pars intermediate cells. All pars intermedi
ate cells were equally stained by alpha- or beta-MSH and beta-endorphin in
both vehicle- and sCT-treatment. No difference was seen. These findings str
ongly suggest a very close relationship between Pit-1 protein immunoreactiv
ity and cellular proliferation induced by sCT.